oxidopamine has been researched along with Amyloid Deposits in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, B | 1 |
| Maeda, J | 1 |
| Sawada, M | 1 |
| Ono, M | 1 |
| Okauchi, T | 1 |
| Inaji, M | 1 |
| Zhang, MR | 1 |
| Suzuki, K | 1 |
| Ando, K | 1 |
| Staufenbiel, M | 1 |
| Trojanowski, JQ | 1 |
| Lee, VM | 1 |
| Higuchi, M | 1 |
| Suhara, T | 1 |
1 other study available for oxidopamine and Amyloid Deposits
| Article | Year |
|---|---|
Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
Topics: Acetamides; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Cell L | 2008 |